de Courval François P, De Serres Gaston, Duval Bernard
Département de médecine sociale et préventive, Faculté de médecine, Université Laval, Québec.
Can J Public Health. 2003 Jul-Aug;94(4):268-71. doi: 10.1007/BF03403549.
In Canada, varicella vaccine is recommended but its uptake has been low. In contrast to most other recommended paediatric vaccines, this one is not currently provided free of charge in all provinces and territories in Canada.
To evaluate the rate of health care provider offer of varicella vaccine to parents and the most important determinants of parental decision to accept the offer.
A structured questionnaire was administered by phone interview to parents of children aged 14 to 17 months in the Quebec City area where the vaccine is not publicly funded.
Among the 477 participants, 37% had been offered the vaccine by their health care provider: 45% when the provider was a paediatrician and 29% for general practitioners or public health clinics. Only 13% of offers included information on the risk of varicella complications, the cost, efficacy and safety of the vaccine. By decreasing order of importance, the factors that positively increased parental decision to use varicella vaccine included: information on vaccine safety, a positive recommendation and a higher family income.
Despite a recommendation for universal vaccination, varicella vaccine is not broadly offered and few offers contain all the information both needed to elicit proper consent and correlated with a positive uptake.
在加拿大，水痘疫苗是被推荐使用的，但它的接种率一直很低。与大多数其他推荐的儿科疫苗不同，目前在加拿大并非所有省份和地区都免费提供这种疫苗。
评估医疗保健提供者向家长提供水痘疫苗的比例以及家长决定接受该提议的最重要决定因素。
通过电话访谈对魁北克市地区14至17个月大儿童的家长进行了结构化问卷调查，该地区水痘疫苗没有公共资金支持。
在477名参与者中，37% 的家长曾被医疗保健提供者提供过该疫苗：提供者为儿科医生时这一比例为45%，而全科医生或公共卫生诊所提供的比例为29%。只有13% 的提议包含了水痘并发症风险、疫苗成本、疗效和安全性等信息。按重要性降序排列，积极增加家长使用水痘疫苗决定的因素包括：疫苗安全性信息、积极推荐和较高的家庭收入。
尽管推荐普遍接种水痘疫苗，但该疫苗并未广泛提供，很少有提议包含获得适当同意所需的所有信息以及与积极接种相关的信息。
